EVFM 2018 Proxy Statement

7 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information concerning the ownership of our common stock as of February 28, 2018, by (i) those persons who are known to us to be the beneficial owner(s) of more than five percent of our common stock, (ii) each of our directors and named executive officers and (iii) all of our directors and named executive officers as a group. The number of shares beneficially owned by each entity, person, director or executive officer is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership generally includes any shares over which the individual has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60 days of February 28, 2018, through the exercise of stock options, warrants or other rights. Unless otherwise indicated in the footnotes to this table, we believe that each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Name and Address of Beneficial Owner Shares Beneficially Owned Percent of Shares Beneficially Owned 5% Stockholders Entities affiliated with Invesco Ltd. (1) 7,037,498 39.6% 1555 Peachtree Street, N.E. Atlanta, GA 30309 Entities affiliated with Woodford Investment Management Limited (2) † 7,465,538 42.0% 9400 Garsington Road Oxford, OX4 2HN, United Kingdom Directors and Named Executive Officers Thomas Lynch (3) 3,850 * Gillian Greer, Ph.D. — * William Hall, Ph.D., M.D. — * Kim Kamdar, Ph.D. (4) 551,560 3.1% Tony O’Brien — * Colin Rutherford (5) 770 * Saundra Pelletier (6) 34,215 * Justin J. File (7) 12,338 * Kelly Culwell, M.D. (8) 4,962 * Directors and executive officers as a group (11 Persons) (9) 610,688 3.4% * Includes beneficial ownership of less than 1% of the outstanding shares of Evofem’s common stock. † Party to the Post-Merger Voting Agreements, pursuant to which stockholder agreed to vote certain shares of our common stock held by stockholder or over which stockholder has voting control in a certain manner. See the section entitled “Certain Relationships and Related Person Transactions– Post-Merger Voting Agreements” beginning on page 27 of this proxy statement. (1) Invesco Ltd., in its capacity as an investment adviser, may be deemed to beneficially own 7,037,498 shares. Invesco Ltd. is the parent issuer of Invesco UK limited, which is the parent issuer of Invesco Asset Management Limited, which is the manager of the funds and accounts that own the common stock consisting of (i) 3,519,366 shares of common stock owned by Invesco Perpetual High Income Fund and (ii) 3,518,132 shares of common stock held by Invesco Perpetual Income Fund. (2) Includes (i) 5,620,952 shares of common stock held by CF Woodford Equity Income Fund, a sub fund of CF Woodford Investment Fund, or WEIF, (ii) 171,975 shares of common stock held by Omnibus Income & Growth Fund, a sub fund of Omnis Portfolio Investments ICVC, or OIGF, and (iii) 1,672,611 shares of common stock held by Woodford Patient Capital Trust Plc., or WPCT. Woodford Investment Management Limited acts as agent for and on behalf of WEIF, OIGF and WPCT, each as a discretionary managed client. Woodford Investment Management Limited has the power to direct the vote and disposition of the common stock held by WEIF, OIGF and WPCT. Accordingly, Woodford Investment

RkJQdWJsaXNoZXIy NTIzOTM0